MyJournals Home  

RSS FeedsEicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux (Oncogene)

 
 

22 november 2018 02:00:22

 
Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux (Oncogene)
 




 
87 viewsCategory: Oncology
 
Oncogenic activity of poly (ADP-ribose) glycohydrolase (Oncogene)
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors (Cancer Gene Therapy)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten